Cancer cell procoagulants and their role in malignant disease.
about
The cancer stem cell: evidence for its origin as an injured autoreactive T cellThe hypercoagulable state of malignancy: pathogenesis and current debateThe hemostatic system and angiogenesis in malignancy.Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors.
P2860
Cancer cell procoagulants and their role in malignant disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Cancer cell procoagulants and their role in malignant disease.
@ast
Cancer cell procoagulants and their role in malignant disease.
@en
type
label
Cancer cell procoagulants and their role in malignant disease.
@ast
Cancer cell procoagulants and their role in malignant disease.
@en
prefLabel
Cancer cell procoagulants and their role in malignant disease.
@ast
Cancer cell procoagulants and their role in malignant disease.
@en
P356
P1476
Cancer cell procoagulants and their role in malignant disease.
@en
P2093
P304
P356
10.1055/S-2007-1002580
P577
1992-01-01T00:00:00Z